Sirius Therapeutics Funding: $150M Raised, Series B (2025)
Sirius Therapeutics is based in San Diego, California. It has raised $150M in total funding. Latest round: Series B.
Sirius Therapeutics funding overview
Sirius Therapeutics is based in San Diego, California. Sirius Therapeutics has raised $150M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in May 2025. The round record for Sirius Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include OrbiMed, Creacion Ventures, Hankang Capital, BioTrack Capital. 4 distinct backers are named across the disclosed rounds.
Sirius Therapeutics at a glance
Total raised
$150M
Latest round
Series B
Latest round date
May 2025
Headquarters
San Diego, California
Notable investors
OrbiMed, Creacion Ventures, Hankang Capital, BioTrack Capital
Frequently asked about Sirius Therapeutics funding
How much has Sirius Therapeutics raised?
Sirius Therapeutics has raised $150M in total disclosed funding across the rounds on record.
Who has invested in Sirius Therapeutics?
OrbiMed, Creacion Ventures, Hankang Capital, BioTrack Capital are named among the investors backing Sirius Therapeutics.
What was the latest Sirius Therapeutics funding round?
The most recent disclosed round is a Series B, announced in May 2025.
Where is Sirius Therapeutics based?
Sirius Therapeutics is based in San Diego, California.
When did Sirius Therapeutics last raise?
The last disclosed Sirius Therapeutics round closed in May 2025 at Series B.
Totals shown for Sirius Therapeutics aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.
